Stocks That Hit 52-Week Lows On Tuesday
Tuesday's session saw 167 companies set new 52-week lows.
EF Hutton Initiates Coverage On Werewolf Therapeutics with Buy Rating, Announces Price Target of $8.3
EF Hutton analyst Michael King initiates coverage on Werewolf Therapeutics (NASDAQ:HOWL) with a Buy rating and announces Price Target of $8.3.
Stocks That Hit 52-Week Lows On Tuesday
During Tuesday's trading, 160 companies set new 52-week lows.
Werewolf Therapeutics To Present Preclinical Data At Society For Immunotherapy Of Cancer Annual Meeting And Participate In Upcoming Investor Conferences
Werewolf Therapeutics, Inc. (the "Company" or "Werewolf") (NASDAQ:HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics engineered to
Why PolyPid Dipped Over 73%; Here Are 60 Biggest Movers From Friday
Gainers
Venus Concept Inc. (NASDAQ: VERO) jumped 54.9% to settle at $0.5419 on Friday. The company, last month, posted downbeat quarterly results.
